Literature DB >> 1079715

Use of the activated coagulation time in intraoperative heparin reversal for cardiopulmonary operations.

K L Mattox, G A Guinn, P A Rubio, A C Beall.   

Abstract

Activated clotting time (ACT) was used in 300 consecutive patients undergoing cardiac operations to determine the adequacy of heparin reversal. Mean ACT prior to protamine sulfate administration was 9 minutes 40 seconds. A return to normal value (less than 2 min 10 sec) occurred in three-fourths of our patients following administration of 1.5 mg of protamine sulfate for each 100 units of heparin. Additional protamine sulfate was administered in 50 mg doses to those having abnormal ACT until normal clotting was obtained. Normal values for ACT usually coincided with clotting in the operative field. ACT proved to be a reliable guide to protamine sulfate administration.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1079715     DOI: 10.1016/s0003-4975(10)63823-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  All ACTs are not created equal.

Authors:  J J Ferguson
Journal:  Tex Heart Inst J       Date:  1992

Review 2.  The hemostatic defect of cardiopulmonary bypass.

Authors:  Matthew Dean Linden
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

3.  Safety and efficacy of fixed-dose heparin in carotid endarterectomy.

Authors:  A Poisik; E J Heyer; R A Solomon; D O Quest; D C Adams; C M Baldasserini; D J McMahon; J Huang; L J Kim; T F Choudhri; E S Connolly
Journal:  Neurosurgery       Date:  1999-09       Impact factor: 4.654

4.  Risk Factors Associated with Difficult Reversal of Heparin by Protamine Sulfate in Cardiopulmonary Bypass: An Ignored Issue.

Authors:  Min Jung Ku; Su Wan Kim; Seogjae Lee; Jee Won Chang; Jonggeun Lee
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2020-10-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.